Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Congress Narrows Hemp Definition and Bans Synthetic Cannabinoids, Reshaping the THC Market
Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.
Federal Funding Bill Could Ban Most Ingestible Hemp-Derived THC Products
A proposed federal spending bill includes language that could ban most ingestible hemp-derived THC products, threatening an estimated $28 billion industry. The measure would eliminate Delta-8, THCA, and other intoxicating hemp items — reshaping the national marketplace overnight.
How a Woman-Led Biotech Firm Is Advancing Cannabis Medicine
A woman-led biotech company is developing prescription-grade cannabinoid treatments for women’s health conditions like endometriosis. Their work aims to bring cannabis into mainstream medical and pharmaceutical channels — marking a breakthrough moment for both science and the cannabis industry.
Federal Spending Bill Includes Hemp Product Ban
A federal spending bill to reopen the government includes provisions to ban many hemp-derived THC products, such as Delta-8 and hemp-based gummies and beverages. The move could devastate parts of the hemp industry and signals increasing federal intervention in cannabis regulation.
U.S. Hemp Roundtable Warns Senate Proposal Could “Wipe Out” 95% of the Industry
The U.S. Hemp Roundtable warns that new Senate language could “wipe out” 95% of the hemp industry, eliminating thousands of jobs and billions in revenue. The group is urging Congress to remove the proposal from the federal spending bill and pursue balanced hemp regulation instead.
New Study Finds Cannabis Access Linked to Lower Heavy Alcohol Use
A new Oregon study finds that adults living near licensed cannabis stores report less heavy drinking and more marijuana use, especially among Gen Z and Baby Boomers. The findings suggest cannabis access may be replacing alcohol as a preferred wellness or social alternative.
Mainstream Brands Join the Cannabis Space with Hemp-Derived THC Products (Copy)
Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.
Mainstream Brands Join the Cannabis Space with Hemp-Derived THC Products
A major edible-fruit brand is launching hemp-derived THC gummies and beverages aimed at wellness consumers seeking alcohol-free relaxation. The move highlights how mainstream companies are entering the cannabis ecosystem amid evolving regulations and rising consumer demand.
Curaleaf Reports $320M in Revenue, $54.5M Net Loss in Q3
Curaleaf reported Q3 revenue of $320 million and a net loss of $54.5 million, reflecting both strength and ongoing financial strain across large multi-state cannabis operators. The results highlight the industry’s shift toward sustainable growth and disciplined risk management.
Green Thumb Industries Posts Strong Q3 Results Amid Industry Headwinds
Green Thumb Industries (GTI) reported Q3 revenue of $291.4 million, net income of $23.3 million, and $74.1 million in cash flow from operations. The strong performance highlights the company’s disciplined growth strategy and financial stability amid industry headwinds.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.